# A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors

> **NCT07269899** · PHASE1 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 12 (estimated)

## Conditions studied

- Solid Tumor Cancer
- Cancer

## Interventions

- **DRUG:** WTX212A injection
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT07269899
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-25
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-08-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269899, "A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07269899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*